![](https://startllc.com/wp-content/uploads/2024/02/Proscia510k-copy-300x138.jpeg)
Proscia receives FDA 510(k) clearance for Concentriq AP-Dx
Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) clearance from the United States (U.S.) Food and Drug Administration (FDA) for its Concentriq AP-Dx. The digital pathology solution was cleared for the purpose of primary diagnosis.